Camber Pharmaceuticals recalls

Camber Pharmaceuticals appears in 5 official U.S. recall notices indexed by RecallRadar, most recently on 2023-05-17.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 0885…
  FDA Drug · Class I · 2023-05-17 · Camber Pharmaceuticals
• Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway,…
  FDA Drug · Class III · 2022-12-21 · Camber Pharmaceuticals
• Losartan Potassium Tablets USP, 100 mg, Rx only, a) 30 count (NDC 31722-702-30), b) 90 count (NDC 31722-702-30), c) 1000 count (NDC 31722-7…
  FDA Drug · Class II · 2019-03-27 · Camber Pharmaceuticals
• Losartan Potassium Tablets USP, 25 mg, Rx only, a) 90 count (NDC 31722-700-90), b) 500 count (NDC 31722-700-05) and c) 1000 count (NDC 3172…
  FDA Drug · Class II · 2019-03-27 · Camber Pharmaceuticals
• Losartan Potassium Tablets USP, 50 mg, Rx only, a) 30 count (NDC 31722-701-30), b) 90 count (NDC 31722-701-90), c) 1000 count (NDC 31722-70…
  FDA Drug · Class II · 2019-03-27 · Camber Pharmaceuticals